Heparins from porcine and bovine intestinal mucosa: Are they similar drugs?

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH09-11-0761
Issue:2010: 103/5 (May) pp. 875–1108
Pages:1005-1015

Heparins from porcine and bovine intestinal mucosa: Are they similar drugs?

Online Supplementary Material

R. S. Aquino (1), M. S. Pereira (1), B. C. Vairo (1), L. P. Cinelli (1), G. R. C. Santos (1), R. J. C. Fonseca (1), P. A. S. Mourão (1)

(1) Laboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho, Programa de Glicobiologia, Instituto de Bioquímica Médica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Summary

Increasing reports of bleeding and peri- or post-operative blood dyscrasias in Brazil were possibly associated with the use of heparin from bovine instead of porcine intestine. These two pharmaceutical grade heparins were analysed for potential differences. NMR analyses confirmed that porcine heparin is composed of mainly trisulfated disaccharides →4-α-IdoA2S-1→4-α-GlcNS6S-1→. Heparin from bovine intestine is also composed of highly 2-sulfated α-iduronic acid residues, but the sulfation of the α-glucosamine units vary significantly: ~50% are 6- and N -disulfated, as in porcine heparin, while ~36% are 6-desulfated and ~14% N -acetylated. These heparins differ significantly in their effects on coagulation, thrombosis and bleeding. Bovine heparin acts mostly through factor Xa. Compared to porcine heparin on a weight basis, bovine heparin exhibited approximately half of the anticoagulant and antithrombotic effects, but similar effect on bleeding. These two heparins also differ in their protamine neutralisation curves. The doses of heparin from bovine intestine required for effective antithrombotic protection and the production of adverse bleeding effects are closer than those for porcine heparin. This observation may explain the increasing bleeding observed among Brazilian patients. Our results suggest that these two types of heparin are not equivalent drugs.

Keywords

thrombosis, heparins, glycosaminoglycans, Venous thrombosis, Serpins

DOI

http://dx.doi.org/10.1160/TH09-11-0761

You may also be interested in...

1.

Nadine S. Gibson1, Maaike Sohne1, Marieke J. H. A. Kruip2, Lidwine W. Tick3, Victor E. Gerdes1, Patrick M. Bossuyt4, Philip S. Wells5, Harry R. Buller1 on behalf of the Christopher study investigators

Thrombosis and Haemostasis 2008 99 1: 229-234

http://dx.doi.org/10.1160/TH07-05-0321

2.

David Hernández-Espinosa, Adriana Ordóñez, Vicente Vicente, Javier Corral

Thrombosis and Haemostasis 2007 98 3: 557-563

http://dx.doi.org/10.1160/TH07-02-0152

3.

L. K. Young (1, 2), N. P. Birch (3), P. J. Browett (1, 2), P. B. Coughlin (4), A. J. Horvath (4), N. S. Van de Water (5), P. A. Ockelford (2), P. L. Harper (6)

Thrombosis and Haemostasis 2012 107 5: 854-863

http://dx.doi.org/10.1160/TH11-10-0708



Articles

You've 152 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...